Association between maternal obesity, essential fatty acids and biomarkers of fetal liver function

Macarena Ortiz, Francisca Sánchez, Daniela Álvarez, Cristian Flores, Francisca Salas-Pérez, Rodrigo Valenzuela, Claudette Cantin, Andrea Leiva, Nicolás Crisosto, Manuel Maliqueo*

*Autor correspondiente de este trabajo

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

1 Cita (Scopus)

Resumen

Maternal obesity and the imbalance in linoleic acid (C18:2 n-6, LA) and alpha-linolenic acid (C18:3 n-3, ALA) levels are related with hepatic disturbances in the offspring. However, whether these alterations are present during fetal life is not well understood. Obese and normal weight pregnant women were recruited to determine fatty acids (FAs) consumption, FAs profile (in maternal erythrocytes, placenta and neonatal very low-density lipoproteins VLDL) and biomarkers of fetal liver function, such as gamma-glutamyl transferase (GGT), alpha-fetoprotein (AFP) and albumin, in umbilical cord blood. Stearic acid (C18:0, ST) was lower, and total n-3 FAs tended to be lower in umbilical cord VLDLs of obese women compared to controls. Independently of maternal obesity, GGT levels in umbilical cord blood was positively correlated with the LA content and negatively correlated with the ALA content in maternal erythrocytes. We conclude that maternal obesity and its imbalance of LA and ALA are associated with changes in biomarkers of fetal liver function.

Idioma originalInglés
Número de artículo102541
PublicaciónProstaglandins Leukotrienes and Essential Fatty Acids
Volumen190
DOI
EstadoPublicada - 2023

Nota bibliográfica

Publisher Copyright:
© 2023 Elsevier Ltd

Áreas temáticas de ASJC Scopus

  • Bioquímica clínica
  • Biología celular

Huella

Profundice en los temas de investigación de 'Association between maternal obesity, essential fatty acids and biomarkers of fetal liver function'. En conjunto forman una huella única.

Citar esto